<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04935918</url>
  </required_header>
  <id_info>
    <org_study_id>2019-41</org_study_id>
    <nct_id>NCT04935918</nct_id>
  </id_info>
  <brief_title>EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENCE THERAPY BALLOONS IN BLADDER EXSTROPHY AND INCONTINENT EPISPADIAS PATIENTS</brief_title>
  <acronym>ACT</acronym>
  <official_title>PROSPECTIVE STUDY EVALUATING THE SAFETY AND EFFECTIVENESS OF ADJUSTABLE CONTINENCE THERAPY (ACT) BALLOONS FOR THE MANAGEMENT OF URINARY INCONTINENCE IN CHILDREN WITH BLADDER EXSTROPHY OR INCONTINENT EPISPADIAS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness and safety of a minimally invasive&#xD;
      surgical procedure with ACT (Adjustable Continence Therapy) balloons implantation for the&#xD;
      treatment of urinary incontinence in children with bladder exstrophy or isolated epispadias.&#xD;
&#xD;
      The ACT therapy consists of two small adjustable silicone balloons connected with a tubing to&#xD;
      a port, surgically placed around the bladder neck, one on each side of the urethra.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">April 2028</completion_date>
  <primary_completion_date type="Anticipated">April 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the clinical impact of ACT balloon on urinary continence with pad weight</measure>
    <time_frame>24 months</time_frame>
    <description>Therapeutic success will be based on whether patients demonstrate at least a 50% reduction in 24 hour Pad weight at 6, 12 and 24 months follow-up compared to the pad weight results at baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of pads per day (voiding diary)</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Change of number of peds changed per day from baseline to 6, 12 and 24 months (the best : 0 pads changed a day).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of incontinence episodes per day (voiding diary)</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Change in number of incontinence episodes per day from baseline to 6, 12 and 24 months (the best : 0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PIN-Q questionnaire</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Change on validated incontinence quality of life questionnaire from baseline to 6, 12 and 24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of urethral stricture and device erosion after ACT implantation</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Cumulative incidence of ACT related clinically relevant urethral structure and device erosions (the best : 0)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Bladder Exstrophy</condition>
  <arm_group>
    <arm_group_label>Study Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children with bladder exstrophy or isolated epispadias</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACT</intervention_name>
    <description>Implantation of ACT balloon, Uromedica (Irvine, CA, USA) periurethrally at the bladder neck. The ACT system is a permanent implant designed for the correction of incontinence in patients.</description>
    <arm_group_label>Study Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Boys and girls &gt; 5 years with bladder exstrophy or isolated epispadias;&#xD;
&#xD;
          -  sphincteric incontinence (leak point pressure &lt; 45 cm d'H20, open bladder neck during&#xD;
             filling, stress urinary incontinence);&#xD;
&#xD;
          -  normal renal function (eGFR &gt; 90ml/min);&#xD;
&#xD;
          -  no (or stable) upper urinary tract dilatation in ultrasound.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  under 5 years or more than 18 years old;&#xD;
&#xD;
          -  renal insufficiency (acute or chronic);&#xD;
&#xD;
          -  evolutive deterioration of the upper urinary tract (hydronephrosis);&#xD;
&#xD;
          -  unmanageable detrusor instability;&#xD;
&#xD;
          -  residual volume greater than 100 ml after voiding;&#xD;
&#xD;
          -  bleeding disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilie GARRIDO-PRADALIE</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique HÃ´pitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alice FAURE, MD</last_name>
    <phone>04.91.96.81.41</phone>
    <email>alice.faure@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire MORANDO</last_name>
    <phone>04 91 38 21 83</phone>
    <email>claire.morando@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <state>Paca</state>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice FAURE, MD</last_name>
      <phone>04.91.96.81.41</phone>
      <email>alice.faure@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Claire MORANDO</last_name>
      <phone>04 91 38 21 83</phone>
      <email>claire.morando@ap-hm.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 8, 2021</study_first_submitted>
  <study_first_submitted_qc>June 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bladder Exstrophy</mesh_term>
    <mesh_term>Epispadias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

